Rescue therapy for acute migraine, part 1: Triptans, dihydroergotamine, and magnesium

Headache

Volumn 52, Issue 1, 2012, Pages 114-128

  Kelley, Nancy E ^a   Tepper, Deborah E ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

dihydroergotamine; emergency; magnesium; migraine; treatment; triptan

Indexed keywords

BUTORPHANOL; CALCITONIN GENE RELATED PEPTIDE; CHLORPROMAZINE; DEXAMETHASONE; DIHYDROERGOTAMINE; DROPERIDOL; ERGOTAMINE TARTRATE; HYDROXYZINE; KETOROLAC; LIDOCAINE; MAGNESIUM; METOCLOPRAMIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PETHIDINE; PLACEBO; PROCHLORPERAZINE; PROMETHAZINE; RIZATRIPTAN; SUMATRIPTAN; TRIMETHOBENZAMIDE; VALPROIC ACID;

ABDOMINAL CRAMP; ALLODYNIA; ANALGESIA; BURNING SENSATION; CHEST TIGHTNESS; CLINICAL EFFECTIVENESS; DIARRHEA; DISEASE SEVERITY; DIZZINESS; DROWSINESS; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG SAFETY; DYSPHORIA; FLUSHING; FOLLOW UP; GLOSSOPHARYNGEAL NERVE; HEAD AND NECK DISEASE; HEAD PAIN; HEADACHE; HEALTH CARE PERSONNEL; HUMAN; INJECTION SITE DISCOLORATION; INJECTION SITE DISCOMFORT; INJECTION SITE PAIN; LEG PAIN; MIGRAINE; NAUSEA; NECK TIGHTNESS; OUTPATIENT CARE; PAIN; PAIN ASSESSMENT; PATIENT ASSESSMENT; PHONOPHOBIA; PHOTOPHOBIA; PREMEDICATION; PRIORITY JOURNAL; RESTLESSNESS; REVIEW; SEDATION; SENSITIZATION; SIDE EFFECT; SINGLE DRUG DOSE; SKIN TINGLING; THORAX PAIN; TREATMENT CONTRAINDICATION; TREATMENT OUTCOME; TREATMENT RESPONSE; TRIGEMINAL NERVE; VAGUS NERVE; VASOCONSTRICTION; VERTIGO; VOMITING;

ACUTE DISEASE; ANALGESICS, NON-NARCOTIC; DIHYDROERGOTAMINE; HUMANS; MAGNESIUM; MEDLINE; MIGRAINE DISORDERS; TRYPTAMINES;

EID: 84856269552     PISSN: 00178748     EISSN: 15264610     Source Type: Journal    
DOI: 10.1111/j.1526-4610.2011.02062.x     Document Type: Review

References (63)

1. Stovner LJ, Hagen K, Jensen R, et al,. The global burden of headache: A documentation of headache prevalence and disability worldwide. Cephalalgia. 2007; 27: 193-210. (Pubitemid 46354128)
2. Lipton RB, Bigal ME, Diamond M, et al,. Migraine prevalence, disease burden, and need for preventive therapy. Neurology. 2007; 68: 343-349. (Pubitemid 46184209)
3. Goldstein JN, Camargo CA, Pelletier AJ, Edlow JA,. Headache in United States emergency departments: Demographics, work-up and frequency of pathological diagnoses. Cephalalgia. 2006; 26: 684-690.
4. Pitts SR, Niska RW, Xu J, Burt CW,. National Hospital Ambulatory Medical Care Survey: 2006 emergency department summary. Natl Health Stat Report. 2008; 7: 1-38.
5. Vinson DR,. Treatment patterns of isolated benign headache in US emergency departments. Ann Emerg Med. 2002; 39: 215-222. (Pubitemid 34219633)
6. Diamond M, Cady R,. Initiating and optimizing acute therapy for migraine; the role of patient-centered stratified care. Am J Med. 2005; 118 (Suppl. 1): 18S-27S.
7. Gupta MX, Silberstein SD, Young WB, Hopkins M, Lopez BL, Masa GP,. Less is not more: Underutilization of headache medications in a university hospital emergency department. Headache. 2007; 47: 1125-1133. (Pubitemid 47457765)
8. Fiesseler FW, Riggs RL, Shih R, Richman PB,. Do patients with recurrent headaches attempt abortive therapy before their emergency department visit? J Emerg Med. 2007; 32: 245-248. (Pubitemid 46467242)
9. Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders, 2nd edition. Cephalalgia. 2004; 24 (Suppl. 1): 1-160.
10. Blumenthal HJ, Weisz MA, Kelly KM, Mayer RL, Blonsky J,. Treatment of primary headache in the emergency department. Headache. 2003; 43: 1026-1031. (Pubitemid 37543068)
11. Vinson DR, Hurtado TR, Vanenberg JT, Banwart L,. Variations among emergency departments in the treatment of benign headache. Ann Emerg Med. 2003; 41: 90-97. (Pubitemid 36070843)
12. Kelman L,. The broad treatment expectations of migraine patients. J Headache Pain. 2006; 7: 403-406. (Pubitemid 46085244)
13. Lipton RB, Hamelsky SW, Dayno J,. What do patients want from acute migraine treatment? Headache. 2002; 42 (Suppl. 1): 3-9.
14. Friedman BW, Hochberg ML, Esses D, et al,. Recurrence of primary headache disorders after emergency department discharge: Frequency and predictors of poor pain and functional outcomes. Ann Emerg Med. 2008; 52: 696-704.
15. Colman I, Rothney A, Wright SC, Zilkalns B, Rowe BH,. Use of narcotic analgesics in the emergency department treatment of migraine headache. Neurology. 2004; 62: 1695-1700. (Pubitemid 38661721)
16. Bigal ME, Bordini CA, Speciali JG,. Intravenous metamizol (Dipyrone) in acute migraine treatment and in episodic tension-type headache-a placebo-controlled study. Cephalalgia. 2001; 21: 90-95. (Pubitemid 32575470)
17. Krymchantowski AV, Carneiro H, Barbosa J, Jevoux C,. Lysine clonixinate versus dipyrone (metamizole) for the acute treatment of severe migraine attacks: A single-blind, randomized study. Arq Neuropsiquiatr. 2008; 66: 216-220. (Pubitemid 351883905)
18. Cutrer FM,. Pathophysiology of migraine. Semin Neurol. 2010; 30: 120-130.
19. Woods RP, Iacoboni M, Mazziotta JC,. Brief report: Bilateral spreading cerebral hypoperfusion during spontaneous migraine headache. N Engl J Med. 1994; 331: 1689-1692. (Pubitemid 24373622)
20. Burstein R, Collins B, Jakubowski M,. Defeating migraine pain with triptans: A race against the development of cutaneous allodynia. Ann Neurol. 2004; 55: 19-26. (Pubitemid 38067357)
21. Burstein R, Yarnitsky D, Goor-Aryeh I, Ransil BJ, Bajwa ZH,. An association between migraine and cutaneous allodynia. Ann Neurol. 2000; 47: 614-624. (Pubitemid 30261897)
22. Burstein R, Yamamura H, Malick A, Stassman AM,. Chemical stimulation of the intracranial dura induces enhanced responses to facial stimulation in brain stem trigeminal neurons. J Neurophysiol. 1998; 79: 964-982. (Pubitemid 28095912)
23. Tfelt-Hansen P, Block G, Dahlof C,. Guidelines for controlled trials of drugs in migraine: Second edition. Cephalalgia. 2000; 20: 765-786. (Pubitemid 32154559)
24. Goadsby PJ, Edvinsson L, Ekman R,. Vasoactive peptide release in the extracerebral circulation of humans during migraine headache. Ann Neurol. 1990; 28: 183-187. (Pubitemid 20244522)
25. Rapoport AM, Silberstein SD,. Emergency treatment of headache. Neurology. 1992; 32 (Suppl. 2): 43-44.
26. Salonen R, Scott A,. Triptans: Do they differ? Curr Pain Headache Rep. 2002; 6: 133-139.
27. Rapoport AM, Tepper SJ, Bigal ME, Sheftell FD,. The triptan formulations: How to match patients and products. CNS Drugs. 2003; 17: 431-447. (Pubitemid 36560705)
28. Gillman PK,. Triptans, serotonin agonists, and serotonin syndrome (serotonin toxicity): A review. Headache. 2010; 50: 264-272.
29. Hay E, Rodrig J, Hussain A, et al,. Rizatriptan RPD for severe migraine in the emergency department-a multicenter study. J Emerg Med. 2003; 25: 245-249. (Pubitemid 37324659)
30. Miner JR, Smith SW, Moore J, Biros MH,. Sumatriptan for the treatment of undifferentiated primary headaches in the ED. Am J Emerg Med. 2007; 25: 60-64. (Pubitemid 44854385)
31. Akpunonu BE, Mutgi AB, Federman DJ, et al,. Subcutaneous sumatriptan for treatment of acute migraine in patients admitted to the emergency department: A multicenter study. Ann Emerg Med. 1995; 25: 464-469.
32. Winner P, Ricalde O, LeForce B, Saper J, Margul B,. A double-blind study of subcutaneous dihydroergotamine vs subcutaneous sumatriptan in the treatment of acute migraine. Arch Neurol. 1996; 53: 180-184. (Pubitemid 26055266)
33. Kelly AM, Ardagh M, Curry C, D'Antonio J, Zebic S,. Intravenous chlorpromazine versus intramuscular sumatriptan for acute migraine. J Accid Emerg Med. 1997; 14: 209-211.
34. Friedman BW, Corbo J, Lipton RB, et al,. A trial of metoclopramide vs sumatriptan for the emergency department treatment of migraines. Neurology. 2005; 64: 463-468. (Pubitemid 40189864)
35. Friedman BW, Hochberg M, Esses D, et al,. A clinical trial of trimethobenzamide/diphenhydramine vs sumatriptan for acute migraines. Headache. 2006; 46: 934-941. (Pubitemid 43794745)
36. Kostic MA, Gutierrez FJ, Rieg TS, Moore TS, Gendron RT,. A prospective, randomized trial of intravenous prochlorperazine versus subcutaneous sumatriptan in acute migraine therapy in the emergency department. Ann Emerg Med. 2010; 56: 1-6.
37. Meredith JT, Wait S, Brewer KL,. A prospective double-blind study of nasal sumatriptan versus IV ketorolac in migraine. Am J Emerg Med. 2003; 21: 173-175. (Pubitemid 36734676)
38. Jakubowski M, Levy D, Goor-Aryeh I, Collins B, Bajwa Z, Burstein R,. Terminating migraine with allodynia and ongoing central sensitization using parenteral administration of COX1/COX2 inhibitors. Headache. 2005; 45: 850-861. (Pubitemid 41045361)
39. Moskowitz MA,. Basic mechanisms in vascular headache. Neurol Clin. 1990; 8: 801-815. (Pubitemid 20360044)
40. Bell R, Montoya D, Shuaib A, Lee MA,. A comparative trial of three agents in the treatment of acute migraine headache. Ann Emerg Med. 1990; 19: 1079-1082. (Pubitemid 20365193)
41. Saadah H,. Abortive headache therapy in the office with intravenous dihydroergotamine plus prochlorperazine. Headache. 1992; 32: 143-146.
42. Haugh MJ, Lavender L, Jensen A, Giuliano R,. An office-based double-blind comparison of dihydroergotamine vs dihydroergotamine/metoclopramide in the treatment of acute migraine. Headache. 1992; 32: 251.
43. Klapper JA, Stanton JS,. The emergency treatment of acute migraine headache; a comparison of intravenous dihydroergotamine, dexamethasone, and placebo. Cephalalgia. 1991; 11 (Suppl. 11): 159-160.
44. Edwards KR, Norton J, Behnke M,. Comparison of intravenous valproate versus intramuscular dihydroergotamine and metoclopramide for acute treatment of migraine headache. Headache. 2001; 41: 976-980. (Pubitemid 34008133)
45. Klapper JA, Stanton JS,. Ketorolac versus DHE and metoclopramide in the treatment of migraine headaches. Headache. 1991; 31: 523-524.
46. Belgrade MJ, Ling LJ, Schleevogt MB, Ettinger MG, Ruiz E,. Comparison of single-dose meperidine, butorphanol, and dihydroergotamine in the treatment of vascular headache. Neurology. 1989; 39: 590-592. (Pubitemid 19105782)
47. Klapper JA, Stanton JS,. Current emergency treatment of severe migraine headaches. Headache. 1993; 33: 560-562. (Pubitemid 23346606)
48. Scherl ER, Wilson JF,. Comparison of dihydroergotamine with metoclopramide versus meperidine with promethazine in the treatment of acute migraine. Headache. 1995; 35: 256-259.
49. Carleton SC, Shesser RF, Pietrzak MP, et al,. Double-blind, multicenter trial to compare the efficacy of intramuscular dihydroergotamine plus hydroxyzine versus intramuscular meperidine plus hydroxyzine for the emergency department treatment of acute migraine headache. Ann Emerg Med. 1998; 32: 129-138. (Pubitemid 28355501)
50. Callahan M, Raskin N,. A controlled study of dihydroergotamine in the treatment of acute migraine headache. Headache. 1986; 26: 168-171. (Pubitemid 17199220)
51. Foster AC, Fagg GE,. Comparison of L-[3H]glutamate, DL-[3H]AP5 and [3H]NMDA as ligands for NMDA receptors in crude postsynaptic densities from rat brain. Eur J Pharmacol. 1987; 133: 291-300. (Pubitemid 17006467)
52. Altura BM, Altura BT,. Magnesium and vascular tone and reactivity. Blood Vessels. 1978; 15: 5-16. (Pubitemid 8285760)
53. Mody I, Lambert JD, Heinemann U,. Low extracellular magnesium induces epileptiform activity and spreading depression n rat hippocampal slices. J Neurophysiol. 1987; 57: 869-888. (Pubitemid 17047666)
54. Mauskop A, Altura BT, Cracco RQ, Altura BM,. Intravenous magnesium sulfate rapidly alleviates headaches of various types. Headache. 1996; 36: 154-160. (Pubitemid 26116923)
55. Demirkaya S, Vural O, Dora B, Topcuoglu MA,. Efficacy of intravenous magnesium sulfate in the treatment of acute migraine attacks. Headache. 2001; 41: 171-177. (Pubitemid 32209906)
56. Cete Y, Dora B, Ertan C, Ozdemir C, Oktay C,. A randomized perspective placebo-controlled study of intravenous magnesium sulfate vs metoclopramide in the management of acute migraine attacks in the Emergency Department. Cephalalgia. 2004; 25: 199-204. (Pubitemid 40321712)
57. Corbo J, Esses D, Bijur PE, Iannaccone R, Gallager EJ,. Randomized clinical trial of intravenous magnesium sulfate as an adjunctive medication for emergency department treatment of migraine headache. Ann Emerg Med. 2001; 38: 621-627. (Pubitemid 33131559)
58. Bigal ME, Bordini CA, Tepper SJ, Speciali JG,. Intravenous magnesium sulfate in the acute treatment of migraine without aura and migraine with aura. A randomized double-blind, placebo-controlled study. Cephalalgia. 2002; 22: 345-353. (Pubitemid 36613285)
59. Ginder S, Oatman B, Pollack M,. A prospective study of I.V. magnesium and I.V. prochlorperazine in the treatment of headaches. J Emerg Med. 2000; 18: 311-315. (Pubitemid 30154068)
60. Frank LR, Olson CM, Shuler KB, Gharib SF,. Intravenous magnesium for acute benign headache in the emergency department: A randomized double-blind placebo-controlled trial. CJEM. 2004; 6: 327-332. (Pubitemid 40631955)
61. Friedman BW, Mulvey L, Esses D, et al,. Metoclopramide for acute migraine: A dose-finding randomized clinical trial. Ann Emerg Med. 2011; 57: 475-482.
62. Diener HC, Limmroth V,. Medication-overuse headache: A worldwide problem. Lancet Neurol. 2004; 3: 475-483. (Pubitemid 38903098)
63. Torelli P, Campana V, Cervellin G, Mansoni GC,. Management of primary headache in adult emergency departments: A literature review, the Parma Ed experience and a therapy flow chart proposal. Neurol Sci. 2010; 31: 545-553.